Cystic Fibrosis and Genotype-Dependent Therapy: Is There a Need for a Sex-Specific Therapy?
Cystic fibrosis (CF) is an autosomal recessive genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulation (CFTR) anion channel. Loss of CFTR protein and/or function disrupts chloride, bicarbonate, and fluid transport and also impacts epithelial sodium transport....
Main Author: | Neil A. Bradbury PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-07-01
|
Series: | Gender and the Genome |
Online Access: | https://doi.org/10.1177/2470289720937025 |
Similar Items
-
Two Unanticipated Pregnancies While on Cystic Fibrosis Gene-Specific Drug Therapy
by: Sigrid Ladores PhD, RN, PNP, CNE, et al.
Published: (2020-02-01) -
Emerging therapies in cystic fibrosis
by: Paula Anderson
Published: (2010-06-01) -
Gene therapy for the treatment of cystic fibrosis
by: Burney TJ, et al.
Published: (2012-05-01) -
Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype
by: Marika Comegna, et al.
Published: (2021-07-01) -
Enhancing adherence to inhaled therapies in cystic fibrosis
by: Paula Lomas
Published: (2014-04-01)